Anxiofit Ltd. is a developer of scientific evidence-based, anti-anxiety dietary supplements.
All developments are built on deep scientific knowledge, research and numerous animal and human trials to be able to provide with modern, proven help for the growing number of people occasionally experiencing anxiety, stress, nervous inner tension and restless sleep.
The company’s first preparation, EP107™ is successfully marketed for more, than 5 years under AnxioCalm
brand in the US.
The main component of EP107™ is an ancient herb Echinacea. Echinacea is traditionally used for immune support for the respiratory track, but a group of Hungarian scientists found that a unique type of Echinacea Angustifolia from selected growing areas, in a well measured dose, has proven anxiolytic effects. A proper standardization ensures a characteristic alkamide profile, making such an effect clinically measurable. Beside its effective anxiolytic effect EP107™ does not have sedative side effects as most of the existing preparations.
The company started the commercialization of its products globally and is searching for reliable business partners for distribution.
MEET THE TEAM
Chairman of the Neuroscience Department, P. Pazmany Catholic University. He has been President of the Federation of European Neuroscience Societies and he is the President of the Hungarian Academy of Sciences.
He was an Executive Committee Member and Head of Business Development at Affidea Group one of the fastest growing healthcare service groups in Europe and an early investor and President of Oncompass Medicine
Prof. Tamás F. Freund
Chairman of the Board
Jozsef Haller founded the Behavioral Neurobiology Department of the Institute of Experimental Medicine, Budapest. He obtained the Doctor in Science degree at the Hungarian Academy of Science (2004) in behavioral neurobiology
She has dedicated the majority of professional life to advertising in the Publicis Group where she handled thousands of communication projects and managed the Hungarian branch of the company.
Prof. Jozsef Haller
Head of Marketing
The AnxioCalm dietary supplements in the US & Canada are targeting the large population of people experiencing occasional anxiety, not receiving conventional medical treatment and favouring side effect free herbal medications, which has scientifically described mechanism of action and a measurable effect.
AnxioControl was launced in Hungary and will be marketed in many European countries. Striking brand design, communication material is available for those distributors who prefers to take the final products.
Details are coming soon.